Methods and compositions for the prevention and treatment of anemia
0 Assignments
0 Petitions
Accused Products
Abstract
Methods for increasing and maintaining hematocrit in a mammal comprising administering a hyperglycosylated analog of erythropoietin are disclosed. An analog may be administered less frequently than an equivalent molar amount of recombinant human erythropoietin to obtain a comparable target hematocrit and treat anemia. Alternatively, a lower molar amount of a hyperglycosylated analog may be administered to obtain a comparable target hematocrit and treat anemia. Also disclosed are new hyperglycosylated erythropoietin analogs, methods of production of the analogs, and compositions comprising the analogs.
23 Citations
66 Claims
-
1-44. -44. (canceled)
-
45. A method of raising and maintaining hematocrit in a mammal comprising administering a therapeutically effective amount of an analog of erythropoietin in a pharmaceutical composition, wherein the analog comprises the amino acid sequence of human erythropoietin from residues 1-165 as shown in SEQ ID NO:
- 1 except for one or more amino acid changes which provide for one or more additional glycosylation site(s) as compared to human erythropoietin, wherein one additional site is introduced at position 52, 53, 55, 86 or 114 and an N-linked carbohydrate chain is attached at said one additional site.
- View Dependent Claims (46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)
Specification